An NIH-funded postdoctoral position is available in the Plemper lab at Georgia State University in Atlanta. We develop applicable antiviral therapeutics against major respiratory RNA viruses such as influenza virus (Science Translational Medicine 2019; PMID: 31645453), paramyxoviruses (Nature Microbiology 2020; PMID: 32661315), and SARS-CoV-2 (DOI: 10.21203/rs.3.rs-89433/v1). Research in the lab covers all stages of modern pre-clinical drug development including identification of druggable targets, assay development, automated high-throughput drug screening, hit-to-lead development, mechanistic and structural characterization, pharmacological profiling, and efficacy assessment in animal models and disease-relevant human tissue organoids.
The successful candidate will join an experienced team to develop and efficacy-profile next-generation coronavirus inhibitors. A sound foundation in cell biology and/or molecular virology is essential, as is the ability to work in an interdisciplinary team. We seek highly motivated applicants with a strong desire to advance basic scientific discoveries to applicable antiviral drugs. Candidates with prior experience in animal or organoid models of viral infection are particularly encouraged to apply.
The Plemper lab is located in the recently established Institute for Biomedical Sciences at Georgia State University, which ranks among the top in NIH funding per faculty member nationally. The city of Atlanta is a vibrant biomedical research and virology hub, combining big-city opportunities with unique research infrastructure, affordable cost of living and a pleasant climate.
To apply, send a cover letter outlining main past research accomplishments and overarching postdoctoral training goals, full CV, and the contact information of three references to Dr. Richard Plemper at email@example.com.